• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CZZ
Click for more information
0.00% $20.92

CAPILANO HONEY LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CZZ
Ann: Removal from Official List 		07/12/18 0 2.5K
07/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  2.5K 
CZZ
Ann: Final Directors Interest Notice - J Pascoe 		05/12/18 0 1.1K
05/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  1.1K 
CZZ
Ann: Final Directors Interest Notice - R Newey 		05/12/18 0 796
05/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  796 
CZZ
Ann: Change of Directors Interest Notice - B McKee 		05/12/18 0 1.4K
05/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  1.4K 
CZZ
Ann: Final Directors Interest Notice - V Tripp 		05/12/18 0 654
05/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  654 
CZZ
Ann: Final Directors Interest Notice - B O'Donnell 		05/12/18 0 566
05/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  566 
CZZ
Ann: Final Directors Interest Notice - T Morgan 		05/12/18 0 1.7K
05/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  1.7K 
CZZ
Ann: Scheme - Implementation 		05/12/18 0 1.0K
05/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  1.0K 

See All Discussions arrow Created with Sketch.

Featured News

THR Thor reports 200% increase in tungsten at NT's Molyhil
right-arrow Created with Sketch.
RCE Recce steps up defence ties with burn gel presentation at Military conference
right-arrow Created with Sketch.
EDE Record shale gas and fracking drives demand for Eden's Optiblend in the USA
right-arrow Created with Sketch.
PAA PharmAust reappoints MD and resets its sights on MND battle
right-arrow Created with Sketch.
NEWS Making the best of an inflationary environment
right-arrow Created with Sketch.
NEWS The Big Deal: Welcoming Warren Tredrea's words on the business of sport
right-arrow Created with Sketch.

Top Stories

AFT reaches US distribution milestone for Maxigesic Rapid tablets

AFT Pharmaceuticals Ltd has announced a distribution deal with American wholesaler Alexso in relation to its Maxigesic Rapid tablets.
Drilling doubles gold-copper mineralisation zone at GEO-01 for Antipa Antipa Minerals Ltd has announced it has doubled the mineralisation zone of its GEO-01 target in Western Australia through drilling.
Immutep targets $100m for lung cancer drug trial tests Immutep has launched a capital raise aiming to boost its war chest by $100 million to progress late stage trials for lung cancer sufferers.
Daily ASX Market Open: Commodity prices to weigh | June 4, 2024 The pricing of key commodities will matter this morning – as both iron ore and oil were tipped to fall on overseas markets - and that’s set to weigh on the ASX200. Futures suggests the index will tip just slightly into the red (0.13%).
Daily Market ASX Update: Waning profits suppress index | June 4, 2024 The ASX200 responded well to the latest corporate profits data from the ABS, but not enough to push the market into the green.In March, Australia’s gross corporate profits fell -2.5%, far below analyst estimates of just -0.9% for the month.This fresh evidence of a cooling economy ...

Featured News

SPA Spacetalk makes European Market Reentry with Elisa
right-arrow Created with Sketch.
TLX Telix testing shows efficacy of anti-prostate cancer therapy
right-arrow Created with Sketch.
TLG Talga shows expansion options for Sweden's Vittangi graphite project
right-arrow Created with Sketch.
IMM Immutep targets $100m for lung cancer drug trial tests
right-arrow Created with Sketch.
AVH FDA greenlights Avita's RECELL GO skin transplant cell harvesting device
right-arrow Created with Sketch.
PAA PharmAust reappoints MD and resets its sights on MND battle
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.